7 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
EURO EWING Consortium – International Clinical Trials to Improve Survival from Ewing Sarcoma (EEC)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2018,
Ewing Sarcomas (ES) are fatal, rare bone cancers particularly affecting young people. About 60% of patients achieve long term survival with current treatment but there has been no improvement in this proportion for 25 years. Treatment is unsuccessful because chemotherapy fails to prevent the development of, or to effectively treat established, metastases. In addition, of the 600 new cases of ES o ...
Voir le projet
21
Participants partenaires
TERMINÉ
Optimized Diagnostics for Improved Treatment Stratification in Invasive Fungal Diseases (FUNGITECT)
Date du début: 1 févr. 2014, Date de fin: 31 janv. 2018,
"Invasive fungal disease (IFD) is a leading cause of morbidity and mortality in the growing number of immunocompromised individuals, including particularly cancer patients, and bone-marrow or organ transplant recipients. The majority of IFD events are still caused by Candida and Aspergillus species, but there is an increasing incidence of resistant or previously uncommon moulds, yeasts and Zygomyc ...
Voir le projet
6
Participants partenaires
TERMINÉ
Targeted Modulation of Immune-System Responses in Cell Therapies (MODICELL)
Date du début: 1 janv. 2013, Date de fin: 31 déc. 2016,
... know-how. One academic institution will provide computer modelling to generate predictions on the interaction of immune cells under various conditions, providing hits for the other partners to test. The SMEs will use different but complementary strategies for enhancing anti-cancer immune therapies. On the other side of the immune spectrum, another academic partner will focus at enhancing toleranc ...
Voir le projet
5
Participants partenaires
TERMINÉ
International study for treatment of childhood relapsed ALL 2010 with standard therapy, systematic integration of new agents, and establishment of standardized diagnostic and research (INTREALL)
Date du début: 1 oct. 2011, Date de fin: 30 sept. 2016,
Though survival of children with acute lymphoblastic leukaemia (ALL) has improved, relapse remains a leading cause of mortality in childhood cancer. Given the rarity of the disease, only a large international cooperative group can recruit sufficient patients for prospective studies with specific questions in biologic subgroups. Under the umbrella of the I-BFM SG all relevant mainly European study ...
Voir le projet
29
Participants partenaires
TERMINÉ
ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours (ASSET)
Date du début: 1 nov. 2010, Date de fin: 30 avr. 2016,
Cancer is hallmarked by multiple genetic aberrations that lead to a functional derangement of cellular signalling networks. Embryonal tumours (ETs) comprising neuroblastoma, medulloblastoma and Ewing sarcoma, occur early in life, and thus may reveal pathogenetically relevant lesions clearer than adulthood tumours which carry passenger mutations accumulated during life. ASSET will exploit this fact ...
Voir le projet
20
Participants partenaires
TERMINÉ
EUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENTS (ENCCA)
Date du début: 1 janv. 2011, Date de fin: 31 déc. 2015,
"ENCCA aims to establish a durable, European Virtual Institute clinical and translational research in childhood and adolescent cancers that will define and implement an integrated research strategy and will facilitate the necessary investigator-driven clinical trials to introduce the new generation of biologically targeted drugs into standard of care for children and adolescents with cancer. This ...
Voir le projet
34
Participants partenaires
TERMINÉ
DIsseminate Research funded by EC improving Treatment options for children suffering from cancer (DIRECT)
Date du début: 1 mars 2008, Date de fin: 31 oct. 2010,
"Science is an endeavour that relies on a society committed to allocate substantial resources to its pursuit. Clear communication of research projects and their results is an essential part of performing science with public funds. However, progress in science is often slow, achievements of relevance to the society occur mostly in many iterative steps and the benefit for the public can hardly ever ...
Voir le projet